Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Brain ; 141(3): 698-712, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29365063

ABSTRACT

Polymicrogyria is a malformation of cortical development. The aetiology of polymicrogyria remains poorly understood. Using whole-exome sequencing we found de novo heterozygous missense GRIN1 mutations in 2 of 57 parent-offspring trios with polymicrogyria. We found nine further de novo missense GRIN1 mutations in additional cortical malformation patients. Shared features in the patients were extensive bilateral polymicrogyria associated with severe developmental delay, postnatal microcephaly, cortical visual impairment and intractable epilepsy. GRIN1 encodes GluN1, the essential subunit of the N-methyl-d-aspartate receptor. The polymicrogyria-associated GRIN1 mutations tended to cluster in the S2 region (part of the ligand-binding domain of GluN1) or the adjacent M3 helix. These regions are rarely mutated in the normal population or in GRIN1 patients without polymicrogyria. Using two-electrode and whole-cell voltage-clamp analysis, we showed that the polymicrogyria-associated GRIN1 mutations significantly alter the in vitro activity of the receptor. Three of the mutations increased agonist potency while one reduced proton inhibition of the receptor. These results are striking because previous GRIN1 mutations have generally caused loss of function, and because N-methyl-d-aspartate receptor agonists have been used for many years to generate animal models of polymicrogyria. Overall, our results expand the phenotypic spectrum associated with GRIN1 mutations and highlight the important role of N-methyl-d-aspartate receptor signalling in the pathogenesis of polymicrogyria.


Subject(s)
Mutation/genetics , Nerve Tissue Proteins/genetics , Polymicrogyria/genetics , Receptors, N-Methyl-D-Aspartate/genetics , Animals , Child , Child, Preschool , DNA Mutational Analysis , Excitatory Amino Acid Agonists/pharmacology , Family Health , Female , Glutamic Acid/pharmacology , Glycine/metabolism , Glycine/pharmacology , HEK293 Cells , Humans , Infant , Magnetic Resonance Imaging , Male , Membrane Potentials/genetics , Models, Molecular , Mutagenesis/genetics , N-Methylaspartate/pharmacology , Patch-Clamp Techniques , Polymicrogyria/diagnostic imaging , Rats , Transfection
2.
Cell Signal ; 24(3): 770-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22120528

ABSTRACT

The growth of a pluripotent embryonic stem (ES) cell population is dependent on cell survival, proliferation and self-renewal. The nucleotide ATP represents an important extracellular signalling molecule that regulates the survival of differentiated cells, however, its role is largely undefined in embryonic stem cells. Here we report a role for ATP-gated P2X7 receptors in ES cell survival. The functional expression of P2X7 receptors in undifferentiated mouse ES cells is demonstrated using a selective P2X7 antagonist and small interfering RNA knockdown of these receptors. Our data illustrate a key role for the P2X7 receptor as an essential pro-survival signal required for optimal ES cell colony growth in the presence of leukemia inhibitor factor (LIF). However, chronic exposure to exogenous ATP leads to rapid P2X7-dependent cell death via necrosis. Together, these data demonstrate a novel role for P2X7 receptors in regulation of ES cell behaviour where they can mediate either a pro-survival or pro-death signal depending on the mode of activation.


Subject(s)
Embryonic Stem Cells/cytology , Embryonic Stem Cells/physiology , Receptors, Purinergic P2X7/physiology , Signal Transduction , Adenosine Triphosphate/pharmacology , Animals , Apoptosis , Cell Proliferation , Cell Survival , Cells, Cultured , Embryonic Stem Cells/metabolism , Gene Expression Regulation/drug effects , Human Umbilical Vein Endothelial Cells , Humans , Mice , Patch-Clamp Techniques , Purinergic P2X Receptor Antagonists/pharmacology , RNA Interference , RNA, Small Interfering/metabolism , Receptors, Purinergic P2X7/chemistry , Receptors, Purinergic P2X7/genetics , Receptors, Purinergic P2X7/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...